Kathy D. Miller

Indiana University Health

Full Professor(heuristic)

Cancer Treatment and Pharmacology · Oncology

h-index75

i10-index245

Publications749

Citations25,193

Grants

14 total · 4 active

NIH #1UG1CA308564-01

Building upon a tradition of excellence. The NCTN at IUSCCC

Active

Amount: $NaNK
Period: 2026-04-20 → 2032-02-29
PIs: 1
Est. capacity / PI: ~ students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5U01CA278865-03

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

Active

Amount: $NaNK
Period: 2024-05-15 → 2029-04-30
PIs: 2
Est. capacity / PI: ~ students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

NIH #5U01CA278865-02

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

Active

Amount: $NaNK
Period: 2024-05-15 → 2029-04-30
PIs: 2
Est. capacity / PI: ~ students

Awarded at INDIANA UNIVERSITY INDIANAPOLIS

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0045

PageRank within Oncology co-authorship network

Explore collaboration map

Admission Signals

New paper: Impact of patient‐reported taxane‐induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG‐ACRIN EAZ171 (UNC Libraries)2026-06-11
New NIH award: Building upon a tradition of excellence. The NCTN at IUSCCC2026-04-20
New NIH award: The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability2024-05-15
New NIH award: The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability2024-05-15
New NIH award: The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability2024-05-15

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0002-7125-883X

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 79

Impact of patient‐reported taxane‐induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG‐ACRIN EAZ171
UNC Libraries · 2026-06-11
Impact of patient‐reported taxane‐induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG‐ACRIN EAZ171
Cancer · 2026-05-29
Patterns of failure and outcomes in triple-negative compared to estrogen receptor–positive breast cancer.
Journal of Clinical Oncology · 2026-05-28
Influence of TONSL on tumor suppressor function of RAD51 and resistance to CDK4/6 inhibitors in ER+ breast cancer.
Journal of Clinical Oncology · 2026-05-27
EA1181: Accuracy of pre-surgery MRI to predict pathologic complete response after taxane, trastuzumab, and pertuzumab (THP) in HER2-positive breast cancer.
Journal of Clinical Oncology · 2026-05-27
Abstract CT072: Novel targeting of the microenvironment to decrease metastatic recurrence of high-risk TNBC: A randomized phase II study of tetrathiomolybdate (TM) plus capecitabine in patients with breast cancer at high risk of recurrence
Cancer Research · 2026-04-17
A phase 1 study of ASTX727 plus talazoparib in patients with triple‐negative or hormone resistant/HER2‐negative metastatic breast cancer
Cancer · 2026-04-14
Abstract 7293: The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability
Cancer Research · 2026-04-03
Abstract 6287: Ancestry-enriched ACKR1 germline variant and its functional impact on normal and breast cancer biology.
Cancer Research · 2026-04-03
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial
JCO oncology advances. · 2026-04-01
A Co-Design Study Developing an Early Prototype Intervention to Support Oral Anticancer Medication Use in Breast Cancer
Patient Preference and Adherence · 2026-02-01
Supplementary Table S1-S2 from Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103
2025-11-25
Table S11 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S10 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S14 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S13 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S6 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S15 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S8 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24
Table S7 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
2025-11-24

Open author page on OpenAlex →

Kathy D. Miller

Grants

Building upon a tradition of excellence. The NCTN at IUSCCC

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

All Grants

Building upon a tradition of excellence. The NCTN at IUSCCC

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

The impact of oxygen exposure on clinical biomarkers - an underrecognized source of pre-analytic variability

Clinical Protocol and Data Management

Clinical Protocol and Data Management

Clinical Protocol and Data Management

Building upon a tradition of excellence. The NCTN at Indiana University

Building upon a tradition of excellence. The NCTN at Indiana University

Building upon a tradition of excellence. The NCTN at Indiana University

Building upon a tradition of excellence. The NCTN at Indiana University

Building upon a tradition of excellence. The NCTN at Indiana University

Eastern Cooperative Oncology Group

Clinical Protocol and Data Management

Career Trajectory

Research Cluster Map

Potential Collaborators

Recent Publications